AIDS Vaccine Week back issues from June 2009:
New contraceptive device is designed to prevent sexual transmission of HIV.
Jun 01, 2009 ... Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are ...
Study data from National Institute of Allergy and Infectious Diseases update knowledge of allergies.
Jun 01, 2009 ... According to a study from the United States, "Friend virus (FV) is a murine retrovirus that causes acute disease leading to lethal erythroleukemia in most strains of mice. Strains of mice that mount strong and rapid immune responses can recover from acute infection, but nevertheless ...
Reports from A.J. Donayretorres et al highlight recent research in HIV/AIDS.(Report)
Jun 01, 2009 ... "Gag protein from HIV-1 is a polyprotein of 55 kDa, which, during viral maturation, is cleaved to release matrix p17, core p24 and nucleocapsid proteins. The p24 antigen contains epitopes that prime helper CD4 T-cells, which have been demonstrated to be protective and it can elicit ...
Reports from D. Ruchansky et al highlight recent research in HIV/AIDS.(Report)
Jun 01, 2009 ... According to recent research published in the journal AIDS Research and Human Retroviruses, "Recombination has been shown to be an important force in HIV-1 evolution. Recombination contributes to an increase in genetic variation and hinders vaccine design efforts." "Several ...
Studies from AIDS Center have provided new data on HIV/AIDS.
Jun 01, 2009 ... "We previously reported that cynomolgus monkeys vaccinated with the human immunodeficiency virus (HIV)-1 Tat protein controlled infection after challenge with the simian human immunodeficiency virus (SHIV) 89.6P(cy243) for up to 2 y of follow-up. To evaluate the breadth of the protective ...
Research from National Taiwan University in the area of immunization published.
Jun 01, 2009 ... "We aimed to assess the impact of nationwide hepatitis B virus (HBV) vaccination program on the seroprevalence of HBV infection among human immunodeficiency virus (HIV)-positive persons in a country where most HBV exposure occurs during the perinatal period or in early childhood. Data on ...
New gene therapy findings from Paul-Ehrlich-Institute published.
Jun 01, 2009 ... Investigators publish new data in the report 'Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.' "We pseudotyped HIV-1 vectors with cytoplasmic tail-truncated envelope glycoproteins of a wild-type (WT) measles virus (MV)," ...
National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action.(Discussion)
Jun 01, 2009 ... Today, on the second annual World Hepatitis Day, more than 200 viral hepatitis groups around the world have planned observances to raise global awareness, and calling for international and national support for improvements in prevention, diagnosis, treatment and support for people living ...
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope.
Jun 01, 2009 ... Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone. There are over 1.1 million people living with the virus in the ...
Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine.
Jun 01, 2009 ... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced that Chuck Panozzo, founder of the internationally ...
Novel Vaccine Approach Offers Hope in Fight Against HIV.
Jun 01, 2009 ... A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers. By using gene transfer technology that produces molecules that block infection, the ...
Piecing Together the HIV Prevention Puzzle.
Jun 01, 2009 ... "It's an exciting time in HIV prevention research. We will see results from a number of critically important HIV prevention research trials this year, as well as see the start of new trials around the world that will yield important answers in the years to come," said Mitchell Warren, AVAC ...
New Advances on the Long Road to the Development of an AIDS Vaccine.
Jun 01, 2009 ... World AIDS Vaccine Day, May 18, marks the occasion in 1997 when U.S. President Bill Clinton challenged researchers to come up with an AIDS vaccine within the following decade, stating that such a vaccine was the only way to eliminate the threat of AIDS. Twelve years later, the goal of an ...
Research from University of California, Medical Department yields new findings on DNA vaccines.
Jun 08, 2009 ... According to a study from the United States, "Simian immunodeficiency virus (SIV) infection of rhesus macaques is a valuable animal model for human immunodeficiency virus (HIV)-1 vaccine development. Our laboratory recently described the immunogenicity and limited efficacy of a vif-deleted ...
New HIV/AIDS study findings have been reported by D. Promkhatkaew and co-researchers.
Jun 08, 2009 ... According to recent research published in the Southeast Asian Journal of Tropical Medicine and Public Health, "We have previously reported that live vector-based HIV-1 gag vaccine candidate using BCG as a vector was achievable in BALB/c mice. Although the gag-specific CTL induced by this ...
New HIV/AIDS study results reported from G. Koopman et al.
Jun 08, 2009 ... According to a study from Rijswijk, Netherlands, "Human immunodeficiency virus (HIV) infection in humans and simian immunodeficiency virus (SIV) infection in macaques are accompanied by a combined early loss of CCR5 (CD195)-expressing CD4(+) memory T cells, loss of T-helper function and ...
Report summarizes HIV/AIDS study findings from N. Scotti and co-researchers.(Report)
Jun 08, 2009 ... According to recent research from Portici, Italy, "Plants have been recognized as a promising production platform for recombinant pharmaceutical proteins. The human immunodeficiency virus Gag (Pr55(gag)) structural polyprotein precursor is a prime candidate for developing a HIV-1 vaccine, ...
Research from S. Gaseitsiwe and co-researchers in the area of HIV/AIDS published.
Jun 08, 2009 ... "Identification of major histocompatibility complex (MHC) class II binding peptides is a crucial step in rational vaccine design and immune monitoring. We designed a novel MHC class II molecule-peptide microarray binding assay and evaluated 346 peptides from already identified human ...
Researchers from University of California report on findings in simian immunodeficiency virus.(Report)
Jun 08, 2009 ... According to a study from the United States, "The potential benefit of using unmethylated CpG oligoribodeoxynucleotides (ODN) as an adjuvant in a therapeutic simian immunodeficiency virus (SIV) vaccine consisting of AT2-inactivated SIVmac239 was evaluated in SIV-infected rhesus macaques ...
Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need for Next Generation Treatments.
Jun 08, 2009 ... Leaders in biotechnology research and patient advocacy joined forces today at the 2009 BIO International Convention to discuss the latest breakthroughs in HIV/AIDS treatments. Following a keynote speech by Sir Elton John focused on the needs of the HIV/AIDS community, representatives of ...
Sir Elton John Delivers Keynote Today at 2009 BIO International Convention.
Jun 08, 2009 ... Sir Elton John delivered today's keynote address at the 2009 BIO International Convention at the Georgia World Congress Center in Atlanta. He focused on the HIV/AIDS epidemic, how biotechnology has influenced prevention and treatment of the disease and an outlook of the challenges and ...
Sir Elton John, Burrill, Greenwood and Health Care Leaders Headline Day Two of the 2009 BIO International Convention.
Jun 08, 2009 ... Sir Elton John addressed more than 3,000 global attendees today on the HIV/AIDS epidemic on day two of the 2009 BIO International Convention. This global event for biotechnology runs through Thursday May 21. BIO President and CEO Jim C. Greenwood also gave his state-of-the-industry address ...
ImmunoVaccine Technologies Partners With FIT Biotech to Advance a Therapeutic HIV Vaccine.
Jun 08, 2009 ... ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based , clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU(R) MultiHIV DNA plasmid with IVT's ...
Scientists develop a new HIV microbicide -- and a way to mass produce it in plants.
Jun 15, 2009 ... In what could be a major pharmaceutical breakthrough, research published online in The FASEB Journal (http://www.fasebj.org) describes how scientists from St George's, University of London have devised a one-two punch to stop HIV. First the report describes a new protein that can kill the ...
Reports summarize HIV/AIDS research from J. Zhao and co-authors.
Jun 15, 2009 ... According to recent research from the United States, "A major challenge for human immunodeficiency virus (HIV)/AIDS vaccines is the elicitation of anti-Env antibodies (Ab) capable of neutralizing the diversity of isolates in the pandemic. Here, we show that high-avidity, but ...
Research from C.A. Semeniuk and co-authors yields new data on HIV/AIDS.
Jun 15, 2009 ... "The p1 region of HIV-1 gag contains the frameshift stem-loop, gag-pol transframe and a protease cleavage site that are crucial for viral assembly, replication and infectivity. Identifying and characterizing CD8(+) epitopes that are under host immune selection in this region will help in ...
Scientists at New York University, Medical Department target HIV/AIDS.
Jun 15, 2009 ... "Epitopes, also known as antigenic determinants, are small clusters of specific atoms within macromolecules that are recognized by the immune system. Such epitopes can be targeted with vaccines designed to protect against specific pathogens," investigators in the United States report (see ...
Research from E. Fukuchi and colleagues has provided new data on human papillomavirus.
Jun 15, 2009 ... According to recent research from the United States, "Persistent infections with oncogenic human papillomavirus (HPV) types are causally related to cervical cancer. Little is known about the distribution of HPV types, independent risk factors of incidence and persistence, and patterns of ...
QIAGEN to Supply Molecular Screening Solutions to Increase Safety of Blood Donations in Brazil.
Jun 15, 2009 ... QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced that it has entered into an agreement to supply molecular sample and assay technologies for a new national, PCR-based blood screening program for HIV and Hepatitis C (HCV) in Brazil. QIAGEN will provide Bio-Manguinhos, the main ...
CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas.
Jun 15, 2009 ... CEL-SCI Corporation (NYSE AMEX: CVM) announced that its collaborators at the University of Hawaii reported on data at the annual American Society for Microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation ...
Reports outline flu vaccines study findings from University Hospital.(Clinical report)
Jun 22, 2009 ... In this recent article published in the journal Clinical Infectious Diseases, scientists in Bern, Switzerland conducted a study "To our knowledge, no study to date has compared the effects of a subunit influenza vaccine with those of a virosomal influenza vaccine on immunocompromised ...
Research from Rutgers University yields new findings on HIV/AIDS.
Jun 22, 2009 ... "In efforts to develop AIDS vaccine components, we generated combinatorial libraries of recombinant human rhinoviruses that display the well-conserved ELDKWA epitope of the membrane-proximal external region of human immunodeficiency virus type 1 (HIV-1) gp41," investigators in the United ...
Research reports on HIV/AIDS from University of Sassari provide new insights.
Jun 22, 2009 ... "Purpose of review In this review, we focus on the clinical features, diagnosis and management of pneumococcal pneumonia in HIV-infected and noninfected patients, with particular attention to the most recent advances in this area. Recent findings Classical clinical features are found in ...
Researchers from University Hospital, Department of Nuclear Medicine detail new studies and findings in the area of HIV/AIDS.(Report)
Jun 22, 2009 ... New research, 'Positron emission tomography in patients suffering from HIV-1 infection,' is the subject of a report. "This paper reviews currently available PET studies performed either to improve our understanding of the pathogenesis of HIV-1 infection or to assess the value of PET ...
Thomas R. Frieden, M.D., M.P.H., Begins Role as CDC Director and ATSDR Administrator.
Jun 22, 2009 ... Thomas R. Frieden, M.D., M.P.H., today became the 16th director of the Centers for Disease Control and Prevention (CDC) and administrator for the Agency for Toxic Substances and Disease Registry (ATSDR). He was named director of CDC by the White House and the Department of Health and Human ...
Unprecedented Scale-Up of Voluntary Male Circumcision Begins in Swaziland and Zambia.
Jun 22, 2009 ... In a significant move from research on male circumcision to full-scale implementation, the Male Circumcision Partnership is launching a massive scale-up of voluntary male circumcision services in Swaziland and Zambia. The Partnership is supported by a five-year, $50 million grant from the ...
2009 Houston Juneteenth Multicultural Health Festival Becomes Largest Health Event in Texas: Festival Moves Indoors to the Cool George R. Brown.
Jun 22, 2009 ... The City of Houston and its Department of Health and Human Services joins the United Health Group's 3rd Annual Houston Juneteenth Multicultural Health Festival (HJMHF) on Saturday, June 13th to promote its MAN UP Initiative. The Festival moves indoors to the George R. Brown Convention ...
NIAID leaders outline research agenda for universal, voluntary HIV testing and treatment.
Jun 22, 2009 ... Could a global program of universal, voluntary, annual HIV testing and immediate treatment for those who test positive effectively extinguish the HIV pandemic? Is such a program feasible? In the June 10 issue of the Journal of the American Medical Association, top HIV/AIDS research leaders ...
As Flu Pandemic Declared, Leaders Must Focus on Poor Countries to Avert 'Bleaker Picture'.
Jun 22, 2009 ... As the World Health Organization today raised the pandemic alert for Influenza A (H1N1) to its highest level, humanitarian specialists are calling on governments and health authorities globally to strengthen poor communities' access to primary health care and protect the most at risk (see ...
Research results from J. Sun and colleagues update understanding of DNA vaccines.
Jun 29, 2009 ... "In higher eukaryotes, introns are usually required for efficient pre-mRNA processing. However, some viruses have alternative approaches involving posttranscriptional regulatory elements (PREs) to enhance intronless heterologous gene expression through enabling stability and 30 end ...
Research from University of Oxford provides new data on HIV/AIDS.
Jun 29, 2009 ... According to recent research from Oxford, the United Kingdom, "Induction of a long-term immunological memory, which can expand and defend the host upon pathogen encounter, is the ''holy grail'' of vaccinology. Here, using a sensitive cultured IFN-gamma ELISPOT assay, we show that 50% (15 ...
Studies from New York University in the area of immunization described.(Report)
Jun 29, 2009 ... "The authors examined hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination rates, hepatitis infection, and health care access in a gym-attending sample of 311 gay, bisexual, and other men who have sex with men (MSM) in New York City. Overall, 69% reported having been vaccinated ...
Research in the area of life sciences reported from A. Bergthaler and colleagues.
Jun 29, 2009 ... "CD8 T cells are recognized key players in control of persistent virus infections, but increasing evidence suggests that assistance from other immune mediators is also needed. Here, we investigated whether specific antibody responses contribute to control of lymphocytic choriomeningitis ...
Research results from D. Mccoy and colleagues update understanding of life sciences.
Jun 29, 2009 ... "The Bill & Melinda Gates Foundation is a major contributor to global health; its influence on international health policy and the design of global health programmes and initiatives is profound. Although the foundation's contribution to global health generally receives acclaim, fairly ...
GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois.(Company overview)
Jun 29, 2009 ... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced that it signed a proposal to discuss a cooperative arrangement with ...
WVU Doctor Works to Reduce Cancer Burden in Africa.
Jun 29, 2009 ... In 2010, cancer will be the single leading cause of death worldwide, overtaking chronic illnesses such as heart disease and stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis and malaria combined. Almost three-quarters of new cases will occur in developing countries, ...
NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine.(Report)
Jun 29, 2009 ... Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease. Attempts to create a vaccine that induces antibodies that prevent HIV infection or disease, however, have ...
Quintiles Increases Capacity to Manage Clinical Studies for Diseases Including Malaria, HIV and Tuberculosis.(Clinical report)
Jun 29, 2009 ... To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles announced the opening of a new office in Accra, Ghana (see also Quintiles). The opening of a Quintiles' office in Ghana, and the ...